Bronchus-associated lymphoid tissue lymphomas: An update of a rare extranodal maltoma

Clinical Lymphoma and Myeloma

Volumn 7, Issue 9, 2007, Pages 566-572

  Zinzani, Pier Luigi ^a,d   Poletti, Venerino ^b   Zompatori, Maurizio ^c   Tani, Monica ^a   Spaggiari, Lucia ^c   Tomassetti, Sara ^b   Broccoli, Alessandro ^a   Derenzini, Enrico ^a   Baccarani, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d Institute of Hematology   (Italy)

Author keywords

Extranodal lymphoma; High resolution computed tomography; Lung cancer; Malt lymphoma

Indexed keywords

ANTHRACYCLINE; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUDARABINE; IBRITUMOMAB TIUXETAN; MITOXANTRONE; OXALIPLATIN; PREDNISONE; RITUXIMAB; THALIDOMIDE; VINCRISTINE;

B CELL LYMPHOMA; BREAST; BRONCHUS ASSOCIATED LYMPHOID TISSUE LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVA; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; GASTROINTESTINAL TUMOR; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; KIDNEY; LIVER; LOW DRUG DOSE; LUNG; LUNG CANCER; LYMPHATIC SYSTEM DISEASE; LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIMODALITY CANCER THERAPY; ORBIT; OUTCOME ASSESSMENT; PATHOGENESIS; PROGNOSIS; PROSTATE; RADIATION DOSE; REVIEW; RISK ASSESSMENT; SALIVARY GLAND; SKIN; THORAX SURGERY; THYROID GLAND; TREATMENT RESPONSE; UTERUS;

EID: 37849001132     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2007.n.042     Document Type: Review

References (67)

1. Sutcliffe SB, Gospodarowicz MK. Clinical features and management of localized extranodal lymphomas. In: Keating A, Armitage J, Burnet A, et al, eds. Haematology Oncology. Vol 2. Cambridge UP; 1992:189-223.
2. Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001; 25:997-1008.
3. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36:69-86.
4. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behaviour: analysis of 108 patients. J Clin Oncol 1997; 15:1624-30.
5. Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999; 17:1254-8.
6. Cavalli F, Isaacson PG, Gascoyne RD, et al. MALT Lymphomas. Hematology Am Soc Hematol Educ Program 2001; 241-58.
7. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95:802-6.
8. Yonezumi M, Suzuki R, Suzuki H, et al. Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses. Br J Haematol 2001; 115:588-94.
9. Addis BJ, Hyjek E, Isaacson PG. Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia. Histopathology 1988; 13:1-17.
10. Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren syndrome. Mayo Clin Proc 1989; 64:920-31.
11. Lim JK, Lacy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol 2001; 54:642-6.
12. Cordier J, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993; 103:201-8.
13. Poletti V, Romagna M, Gasponi A, et al. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis 1995; 50:191-4.
14. Zaer FS, Braylan RC, Zander DS, et al. Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas. Mod Pathol 1998; 11:525-32.
15. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4:644-53.
16. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575-7.
17. Ambrosetti A, Zanotti R, Pattaro C, et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 2004; 126:43-9.
18. Garbe C, Stein H, Dienemann D, et al. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991; 24:584-90.
19. Kurosu K, Yumoto N, Furukawa M, et al. Low-grade pulmonary mucosa-associated lymphoid tissue lymphoma with or without intraclonal variation. Am J Respir Crit Care Med 1998; 158:1613-9.
20. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswold Meeting. J Clin Oncol 1989; 7:1630-6.
21. Begueret H, Vergier B, Parrens M, et al. Primary lung small B-cell lymphoma versus lymphoid hyperplasia: evaluation of diagnostic criteria in 26 cases. Am J Surg Pathol 2002; 26:76-81.
22. Reichenberger F, Wyser C, Gonon M, et al. Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration 2001; 68:109-12.
23. Mhawech P, Krishnan B, Shahab I. Primary pulmonary mucosa-associated lymphoid tissue lymphoma with associated fungal ball in a patient with human immunodeficiency virus infection. Arch Pathol Lab Med 2000; 124:1506-9.
24. Nicholson AG, Wotherspoon AC, Jones AL, et al. Pulmonary B-cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases. Eur Respir J 1996; 9:2022-5.
25. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997; 57:3944-8.
26. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997; 8:979-85.
27. Rosenwald A, Ott G, Stilgenbauer S, et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999; 155:1817-21.
28. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA sttains of H pylori in gastric MALT lymphoma. Blood 2003; 102:1012-8.
29. Okabe M, Inagaki H, Ohshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003; 162:1113-22.
30. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21; q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93:3601-9.
31. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21. is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18:5785-94.
32. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276:1901-9.
33. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001; 158:699-706.
34. Liu H, Hamoudi RA, Ye H, Ruskone-Fourmestraux A, et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol 2004; 125:318-29.
35. Sugiyama T, Asaka M, Nakamura T, et al. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 2001; 120:1884-5.
36. Narvaez JA, Domingo-Domenech E, Roca Y, et al. Radiological features of non-gastric mucosa-associated lymphoid tissue lymphomas. Curr Probl Diagn Radiol 2004; 33:212-25.
37. Rodallec M, Guermazi A, Brice P, et al. Imaging of MALT lymphomas. Eur Radiol 2002; 12:348-56.
38. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999; 14:423-9.
39. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J 2002; 20:750-62.
40. Lee DK, Im JG, Lee KS, et al. B-cell lymphoma of bronchus-associated lymphoid tissue (BALT): CT features in 10 patients. J Comput Assist Tomogr 2000; 24:30-4.
41. Lee IJ, Kim SH, Koo SH, et al. Bronchus-associated lymphoid tissue (BALT) lymphoma of the lung showing mosaic pattern of inhomogeneous attenuation on thin-section CT: a case report. Korean J Radiol 2000; 1:159-61.
42. Poletti V, Gurioli C, Zinzani PL, et al. Pulmonary complications in patients with hematologic disorders. Minerva Pneumol 2006; 45:53-73.
43. Natsag J, Tomiyama N, Inoue A, et al. Pulmonary mucosa-associated lymphoid tissue type lymphoma with increased accumulation of fluorine 18-fluorodeoxyglucose on positron emission tomography. J Comput Assist Tomogr 2005; 29:640-3.
44. King LJ, Padley SP, Wotherspoon AC, et al. Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol 2000; 10:1932-8.
45. Li G, Hansmann ML, Zwingers T et al. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990; 16:519-31.
46. Cordier JF, Fouque D, Laville E et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993; 103:201-8.
47. Ahmed S, Kussick SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004; 40:1320-9.
48. Zinzani PL, Tani M, Gabriele A, et al. Extranodal marginal zone B-cell lymphoma of MALT-rype of the lung: single experience with 12 patients. Leuk Lymphoma 2003; 44:821-4.
49. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101:2489-95.
50. Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001; 25:997-1008.
51. Ferraro P, Trastek VF, Adlakha H, et al. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 2000; 69:993-7.
52. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999; 14:423-9.
53. Fiche M, Caprons F, Berger F et al. Primary pulmonary non-Hodgkin's lymphomas. Histopathology 1995; 26:529-37.
54. Kennedy JL, Natwani BM, Burke JS, et al. Pulmonary lymphomas and other pulmonary lymphoid lesions. A clinicopathologic and immunologic study of 64 patients. Cancer 1985; 56:539-52.
55. Koss M, Hochholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol 1983; 14:1024-38.
56. Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer 1963; 16:928-55.
57. Jager G, Neumeister P, Ouehenberger F, et al. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial. Ann Oncol 2006; 11:1722-3.
58. Jaget G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002; 20:3872-7.
59. Raderer M, Wohrer S, Bartsch R, et al. Phase II study of oxaliplatin for treatment of patients with mucosa associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23:8442-6.
60. Kees M, Raderer M, Metz-Schimmerl S, et al. Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low dose thalidomide. Leuk Lymphoma 2005; 46:1379-82.
61. Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102:2741-5.
62. Raderer M, Jager G, Brugger S, et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003; 65:306-10.
63. Chong FA, Svoboda J, Cherian S, et al. Regression of pulmonary MALT lymphoma after treatment with rituximab. Leuk Lymphoma 2005; 46:1383-6.
64. Harris N, Jaffe E, Stein H, et al. A Revised European-American Classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood 1994; 84:161-71.
65. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860-1.
66. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored International Working Group. J Clin Oncol 1999; 17:1244-53.
67. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.